Discovery of a carboxyl fullerene derivative as a new lipid droplet regulator inhibiting MASLD

调节器 化学 衍生工具(金融) 组合化学 生物化学 立体化学 富勒烯 生物物理学 药理学 脂滴
作者
Toujun Zou,Juan Wan,Rufang Liao,Lan Bai,Xinyan Li,Xu Cheng,Junjie Zhou,Qinchao Tang,Yufeng Zhang,Chong Zhao,Weiyi Qu,Jinjie Yang,Xiang Zhang,Tian Tian,Xinxin Yao,Zhiwei Cai,Song Tian,Jingwei Jiang,Yufeng Hu,Hailong Yang
出处
期刊:Gut [BMJ]
卷期号:75 (2): 382-397 被引量:13
标识
DOI:10.1136/gutjnl-2025-336268
摘要

BACKGROUND: The prevalence of metabolic dysfunction-associated steatotic liver disease (MASLD) is rapidly increasing with high risk to develop cirrhosis, hepatocellular carcinoma (HCC) and other end-stage liver diseases. However, only two drugs, resmetirom and semaglutide, have been approved by the US food and drug administration (FDA) for the treatment of MASLD, with relative low efficient and obvious side effects. Nanomaterials emerged with constantly growing availability of disease therapy benefiting from their well biocompatibility and appropriate properties. OBJECTIVE: The aim of our present study is to identify and fabricate new nanoparticles with high clinical translational potential for MASLD therapy. DESIGN: MASLD capacities in vitro by evaluating their regulatory effects on perilipin-2 (PLIN2), the key molecule in lipid droplet (LD) formation and stability. The exact effects and molecular mechanisms of the identified nanoparticle on MASLD were explored in both cellular and animal models. RESULTS: fullerene (QF70), as the most potent candidate for MASLD therapy. Notably, QF70 could facilitate lysosomal degradation of PLIN2. More importantly, oral administration of QF70 robustly blocked both diet-induced and leptin deficiency-induced MASLD development with significant improvement in obesity and insulin resistance. We further validated the clinical application potential of QF70 in MASLD-related metabolic disorders in a non-primate model. CONCLUSIONS: This study provides proof-of-concept supporting a nanoparticle-based agent as a LD homeostasis-targeted therapeutic to treat MASLD and related metabolic diseases.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
华仔的应助被anbude采纳,获得10
刚刚
刚刚
刚刚
马111发布了新的文献求助10
1秒前
蝈蝈完成签到,获得积分10
1秒前
hbhsjk发布了新的文献求助10
1秒前
水煮电吹风的应助被刘之捷采纳,获得10
1秒前
1秒前
2秒前
小二郎的应助被youyyuy采纳,获得10
2秒前
zhouzhou完成签到,获得积分10
2秒前
上课呢完成签到 ,获得积分10
2秒前
psycancan完成签到 ,获得积分10
2秒前
3秒前
现代的向珊完成签到,获得积分20
3秒前
3秒前
3秒前
3秒前
456完成签到 ,获得积分10
4秒前
4秒前
Yiii完成签到,获得积分10
4秒前
4秒前
Ken发布了新的文献求助10
4秒前
5秒前
大胆鞯完成签到,获得积分10
5秒前
木木完成签到,获得积分10
6秒前
科研通AI6.3的应助被小胖采纳,获得10
6秒前
zmaifyc完成签到,获得积分10
6秒前
6秒前
Running完成签到 ,获得积分10
7秒前
傅敬业发布了新的文献求助10
7秒前
阿楠发布了新的文献求助10
7秒前
yanjia发布了新的文献求助150
7秒前
7秒前
sly完成签到,获得积分20
7秒前
7秒前
7秒前
322小弟发布了新的文献求助10
7秒前
8秒前
时尚的咖啡完成签到,获得积分10
8秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
Social Psychology in the Real World 600
八旗制度の研究 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8180713
求助须知:如何正确求助?哪些是违规求助? 9570752
关于积分的说明 21814119
捐赠科研通 7776960
什么是DOI,文献DOI怎么找? 3433298
关于科研通互助平台的介绍 2557579
邀请新用户注册赠送积分活动 2479287